Europe Non-Alcoholic Steatopatitis Market Status Key Players Analysis, Industry research 2028
The Europe non-alcoholic steatopatitis market is expected to reach US$ 6,765.21 million by 2028 from US$ 496.83 million in 2021. The market is estimated to grow at a CAGR of 45.2% from 2021 to 2028.
Non-Alcoholic Steatohepatitis (NASH) market remains an under-recognized but rapidly growing health concern worldwide. Increasing awareness among both the general public and primary care...